Standard Biotools (LAB) Other Non-Current Liabilities (2010 - 2026)
Standard Biotools (LAB) reported Other Non-Current Liabilities of $4.4 million for Q1 2026, up 27.34% year-over-year from $3.5 million in Q1 2025, and up 265.76% on a QoQ basis from $1.2 million in Q4 2025.
Standard Biotools (LAB) has 17 years of Other Non-Current Liabilities data on file, last reported at $4.4 million in Q1 2026.
- Quarterly Other Non-Current Liabilities rose 27.34% year-over-year to $4.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.4 million (up 27.34% YoY) and the FY2025 annual result came in at $1.2 million, up 14.41% from the prior year.
- Other Non-Current Liabilities improved to $4.4 million in Q1 2026 per LAB's latest filing, from $1.2 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $4.4 million in Q1 2026 and bottomed at $550000.0 in Q1 2023.
- The 5-year median for Other Non-Current Liabilities is $1.2 million (2025), against an average of $1.6 million.
- The widest annual swing landed in 2023, when Other Non-Current Liabilities slumped 63.19%; it then soared 412.73% in 2024.
- Tracing LAB's Other Non-Current Liabilities over 5 years: stood at $961000.0 in 2022, then grew by 10.82% to $1.1 million in 2023, then fell by 0.28% to $1.1 million in 2024, then grew by 14.41% to $1.2 million in 2025, then soared by 265.76% to $4.4 million in 2026.
- Per Business Quant, the three latest LAB Other Non-Current Liabilities figures stand at $4.4 million (Q1 2026), $1.2 million (Q4 2025), and $1.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Standard Biotools | 448.37 Mn | -6.80 Mn | 11.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.44 Mn |
| Dec 31, 2025 | 1.22 Mn |
| Sep 30, 2025 | 1.20 Mn |
| Jun 30, 2025 | 1.25 Mn |
| Mar 31, 2025 | 3.49 Mn |
| Dec 31, 2024 | 1.06 Mn |
| Sep 30, 2024 | 1.51 Mn |
| Jun 30, 2024 | 1.52 Mn |
| Mar 31, 2024 | 2.82 Mn |
| Dec 31, 2023 | 1.07 Mn |
| Sep 30, 2023 | 1.09 Mn |
| Jun 30, 2023 | 843,000.00 |
| Mar 31, 2023 | 550,000.00 |
| Dec 31, 2022 | 961,000.00 |
| Sep 30, 2022 | 1.17 Mn |
| Jun 30, 2022 | 1.30 Mn |
| Mar 31, 2022 | 1.49 Mn |
| Dec 31, 2021 | 882,000.00 |
| Sep 30, 2021 | 954,000.00 |
| Jun 30, 2021 | 276,000.00 |
| Mar 31, 2021 | 1.37 Mn |
| Dec 31, 2020 | 1.33 Mn |
| Sep 30, 2020 | 536,000.00 |
| Jun 30, 2020 | 538,000.00 |
| Mar 31, 2020 | 461,000.00 |
| Dec 31, 2019 | 573,000.00 |
| Sep 30, 2019 | 473,000.00 |
| Jun 30, 2019 | 575,000.00 |
| Mar 31, 2019 | 564,000.00 |
| Dec 31, 2018 | 1.85 Mn |
| Sep 30, 2018 | 2.17 Mn |
| Jun 30, 2018 | 2.00 Mn |
| Mar 31, 2018 | 2.38 Mn |
| Dec 31, 2017 | 5.83 Mn |
| Sep 30, 2017 | 5.37 Mn |
| Jun 30, 2017 | 4.61 Mn |
| Mar 31, 2017 | 3.12 Mn |
| Dec 31, 2016 | 3.26 Mn |
| Sep 30, 2016 | 3.99 Mn |
| Jun 30, 2016 | 3.80 Mn |
| Mar 31, 2016 | 2.44 Mn |
| Dec 31, 2015 | 2.40 Mn |
| Sep 30, 2015 | 2.14 Mn |
| Jun 30, 2015 | 2.10 Mn |
| Mar 31, 2015 | 1.72 Mn |
| Dec 31, 2014 | 1.79 Mn |
| Sep 30, 2014 | 1.62 Mn |
| Jun 30, 2014 | 1.14 Mn |
| Mar 31, 2014 | 888,000.00 |
| Dec 31, 2013 | 651,000.00 |
| Sep 30, 2013 | 362,000.00 |
| Jun 30, 2013 | 310,000.00 |
| Mar 31, 2013 | 205,000.00 |
| Dec 31, 2012 | 237,000.00 |
| Sep 30, 2012 | 264,000.00 |
| Jun 30, 2012 | 302,000.00 |
| Mar 31, 2012 | 338,000.00 |
| Dec 31, 2011 | 374,000.00 |
| Sep 30, 2011 | 330,000.00 |
| Jun 30, 2011 | 318,000.00 |
| Dec 31, 2010 | 341,000.00 |